Please login to the form below

Not currently logged in
Email:
Password:

GW Pharma

This page shows the latest GW Pharma news and features for those working in and with pharma, biotech and healthcare.

NICE backs first cannabis-based drugs, both from GW Pharma

NICE backs first cannabis-based drugs, both from GW Pharma

Updated guidelines from cost-effectiveness watchdog NICE back the use of GW Pharma’s Epidyolex (cannabidiol) for the treatment of seizures in patients with Lennox Gastaut syndrome (LGS) or Dravet syndrome – ... It says GW hasn’t made a submission

Latest news

More from news
Approximately 7 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    A handful of legitimate companies is now pioneering these products, led by GW Pharma, the UK-headquartered firm that has been working in the area since the late 1990s. ... GW Pharma gained an historic approval for its drug Epidiolex from the FDA in June

  • Pharma deals during January 2014 Pharma deals during January 2014

    Another option, open to some European companies, is to raise cash in the US, for example, in early January GW Pharma raised $87.9m on NASDAQ. . ... See a table listing all the major pharma mergers, acquisitions and collaborations agreed during January

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • GW Pharmaceuticals strengthens research and development team GW Pharmaceuticals strengthens research and development team

    I look forward to contributing to GW’s drug discovery efforts and to advancing the next generation of pipeline candidates.”. ... Justin Gover, GW’s chief executive officer, said: “I am delighted to welcome Volker and Ben to GW in these important R

  • GW Pharmaceuticals promotes Adam George to MD GW Pharmaceuticals promotes Adam George to MD

    Gover said: “These important leadership appointments reflect GW’s continuing evolution into a transatlantic commercial-stage biopharmaceutical company. ... In his new role he will be tasked with ensuring GW’s UK operations achieve their strategic

  • GW Pharma appoints Julian Gangolli as North American president GW Pharma appoints Julian Gangolli as North American president

    Appointment coincides with GW Pharma’s US launch. Biopharma company GW Pharma has named Julian Gangolli as its president for North America. ... GW Pharma is also relocating its CEO, Justin Glover, to the US to support its imminent launch in the States.

  • GW hires Pfizer’s Kenneth Sommerville GW hires Pfizer’s Kenneth Sommerville

    Appointed VP clinical research at company specialising in cannabinoids. Dr Kenneth Sommerville has left his role at pharma giant Pfizer to join GW Pharma. ... This is an exciting time to be joining GW, with a number of important products currently under

More from appointments
Approximately 3 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics